Hide Studies Not Open or Pending
Condition(s):Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia; Relapsed/Refractory B-Cell Non-Hodgkin LymphomaLast Updated:November 4, 2022Active, not recruiting
Condition(s):Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaLast Updated:January 12, 2018Terminated
Condition(s):Chronic Refractory Cough (CRC) With Non-atopic Asthma; CRC With Atopic Asthma; Unexplained Chronic Cough; CRC With Chronic Obstructive Pulmonary Disease; CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisLast Updated:March 1, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:March 10, 2023Active, not recruiting
Condition(s):Cardiac Arrest; Sudden DeathLast Updated:September 21, 2022Completed
Condition(s):Metastatic Malignant Solid Neoplasm; Recurrent Lung Small Cell Carcinoma; Recurrent Malignant Solid Neoplasm; Refractory Malignant Solid Neoplasm; Stage III Lung Small Cell Carcinoma AJCC v7; Stage IIIA Lung Small Cell Carcinoma AJCC v7; Stage IIIB Lung Small Cell Carcinoma AJCC v7; Stage IV Lung Small Cell Carcinoma AJCC v7; Unresectable Solid NeoplasmLast Updated:October 10, 2022Terminated
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesLast Updated:July 4, 2016Terminated
Condition(s):Atrial Fibrillation – SymptomaticLast Updated:April 6, 2022Recruiting
Condition(s):SSPELast Updated:December 10, 2021Not yet recruiting
Condition(s):Bone Neoplasm,Malignant Vertebral Column Thoracic SecondaryLast Updated:July 7, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.